Microvascular rarefaction and tissue vascular resistance in hypertension - PubMed (original) (raw)
Microvascular rarefaction and tissue vascular resistance in hypertension
A S Greene et al. Am J Physiol. 1989 Jan.
Abstract
The purpose of this study was to quantitatively estimate the relative contribution of arteriolar rarefaction (disappearance of microvessels) and arteriolar constriction to the increases in total peripheral resistance and changes in the patterns of flow distribution observed in hypertension. A mathematical model of the hamster cheek pouch intraluminal microcirculation was constructed based on data from the literature and observations from our own laboratory. Separate rarefaction and constriction of third-order (3A) and fourth-order (4A) arterioles were performed on the model, and the results were quantified based on the changes of the computed vascular resistance. The degree of increase in resistance depended both on the number and the order of vessels rarefied or constricted and also on the position of those vessels in the network. The maximum increases in resistance obtained in the model runs were 21% for rarefaction and 75% for constriction. Rarefaction, but not constriction, produced large increases in the degree of heterogeneity of blood flow in the various vessel orders. These results demonstrate that vessel rarefaction significantly influences tissue blood flow resistance to a degree comparable with vessel constriction; however, unlike constriction, microvascular rarefaction markedly altered blood flow distribution in our model of the hamster cheek pouch vascular bed. These findings conform with the hypothesis that a significant component of the increase in total peripheral resistance in hypertension may be due to vessel rarefaction.
Similar articles
- Arteriolar and capillary remodelling in hypertension.
Boudier HA. Boudier HA. Drugs. 1999;58 Spec No 1:37-40. Drugs. 1999. PMID: 10526957 Review. - Microcirculation and arterial hypertension.
Vicaut E. Vicaut E. Drugs. 1999;58 Spec No 1:1-10. Drugs. 1999. PMID: 10526952 Review. - Microcirculation and arterial hypertension.
Vicaut E. Vicaut E. Drugs. 1999;59 Spec No:1-10. Drugs. 1999. PMID: 10548386 Review. - The microcirculation and hypertension.
Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H. Struijker Boudier HA, et al. J Hypertens Suppl. 1992 Dec;10(7):S147-56. J Hypertens Suppl. 1992. PMID: 1291649 Review. - Circumferential wall stress as a mechanism for arteriolar rarefaction and proliferation in a network model.
Price RJ, Skalak TC. Price RJ, et al. Microvasc Res. 1994 Mar;47(2):188-202. doi: 10.1006/mvre.1994.1015. Microvasc Res. 1994. PMID: 8022319
Cited by
- Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.
Heuslein JL, Li X, Murrell KP, Annex BH, Peirce SM, Price RJ. Heuslein JL, et al. Microcirculation. 2015 Jul;22(5):360-9. doi: 10.1111/micc.12203. Microcirculation. 2015. PMID: 25866235 Free PMC article. - The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.
Norling AM, Gerstenecker AT, Buford TW, Khan B, Oparil S, Lazar RM. Norling AM, et al. Geroscience. 2020 Feb;42(1):141-158. doi: 10.1007/s11357-019-00139-2. Epub 2019 Dec 5. Geroscience. 2020. PMID: 31808026 Free PMC article. Review. - The Mechanobiology of Vascular Remodeling in the Aging Lung.
Dieffenbach PB, Aravamudhan A, Fredenburgh LE, Tschumperlin DJ. Dieffenbach PB, et al. Physiology (Bethesda). 2022 Jan 1;37(1):28-38. doi: 10.1152/physiol.00019.2021. Epub 2021 Sep 13. Physiology (Bethesda). 2022. PMID: 34514871 Free PMC article. Review. - Microvascular angiogenesis and the renin-angiotensin system.
Greene AS, Amaral SL. Greene AS, et al. Curr Hypertens Rep. 2002 Feb;4(1):56-62. doi: 10.1007/s11906-002-0054-x. Curr Hypertens Rep. 2002. PMID: 11790293 Review. - Mitochondrial dysfunction-mediated decline in angiogenic capacity of endothelial progenitor cells is associated with capillary rarefaction in patients with hypertension via downregulation of CXCR4/JAK2/SIRT5 signaling.
Yu BB, Zhi H, Zhang XY, Liang JW, He J, Su C, Xia WH, Zhang GX, Tao J. Yu BB, et al. EBioMedicine. 2019 Apr;42:64-75. doi: 10.1016/j.ebiom.2019.03.031. Epub 2019 Mar 21. EBioMedicine. 2019. PMID: 30904607 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical